Dibash Kumar Das, PhD

Approximately one-third of young patients were found to have left ventricular systolic dysfunction after acute myocardial infarction.

Use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers was not found to be associated with greater odds of testing positive for COVID-19.

Cardiopulmonary exercise testing may be a useful tool to predict cardiovascular death risk in patients with reduced heart failure with midrange ejection fraction.

Among patients with permanent atrial fibrillation, cognitive impairment may be more common in those with suboptimal antithrombotic therapy, oral anticoagulation, or heart rate control.

A combination of hydroxychloroquine and azithromycin to treat patients with COVID-19 was found to prolong QTc interval without clinically affecting patients.

Transesophageal echocardiography was considered to be a valuable tool for the assessment and management of patients with COVID-19 in critical care.

The treatment of patients with COVID-19 with chloroquine or hydroxychloroquine may result in significant QT prolongation.

The lipid profiles for asymptomatic intracranial arterial stenosis among rural residents in China were found to be characterized by high atherogenic cholesterol, low antiatherogenic cholesterol, and high ratios of atherogenic-to-antiatherogenic cholesterol or lipoproteins.

Limited tablet cardiac ultrasound was found to represent an effective alternative to standard platform imaging for the screening of COVID-19-related cardiac conditions.

Hypolipidemia was found to be associated with COVID-19, and to worsen with disease severity.